1
Second Opinion Podcast – Episode 1: GLP-1 Medications Explained | Ozempic, Wegovy & the Truth About Medical Weight Loss
Second Opinion Podcast – Episode 1: GLP-1 Medications Explained | Ozempic, Wegovy & the Truth About Medical Weight Loss
Mar 4, 2026
1:02:36
Welcome to the Second Opinion Podcast, powered by Rite Care — where we cut through medical misinformation to bring you clear, expert-driven insights from leading specialists.In our inaugural episode, we tackle one of the most searched and debated topics in healthcare today: GLP-1 medications for weight loss.From Ozempic®️ and Wegovy®️ (semaglutide) to Mounjaro®️ and Zepbound®️ (tirzepatide), GLP-1 drugs are transforming the conversation around obesity, metabolic health, and sustainable weight management. But are they a miracle solution — or just one part of a much larger journey?We sit down with Dr. Hillel Peltz, Medical Director of Vital Trak MD and an experienced weight-loss specialist, to break down:How GLP-1 medications workThe medical benefits and potential side effectsLong-term safety and sustainabilityMuscle loss concernsWho is (and isn’t) a good candidateWhether these medications are a long-term solution or a starting pointThen we explore the practical side with Shaul Sultan, a personal trainer based in Lakewood, NJ, who works with many clients using GLP-1 medications. He answers the real-life questions people are asking:Do you still need to diet while on GLP-1s?Is exercise necessary?Will you lose muscle mass?How can you protect your metabolism during weight loss?Whether you’re considering GLP-1 therapy, currently taking semaglutide or tirzepatide, or simply want evidence-based information about medical weight loss, this episode gives you the clarity you’ve been looking for.Contact InformationDr. Hillel Peltz – Vital Trak MD📞 (844) 848-2587Shaul Sultan – Personal Trainer📞 (917) 828-4564SponsorsRite Care — At home, a call away. (732) 292-5665Chemed — Healthcare you have come to trust. (732) 364-6666Vivit — Your Personal Vitamin Concierge. (845) 388-1599Follow us on Instagram: @the secondopinion podcastSubscribe on YouTube